Measuring the indirect and direct costs of acute otitis media

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 1, 1999, Pages 12-18

  Alsarraf, Ramsey ^a   Jung, Chung J ^b   Perkins, Jonathon ^b   Crowley, Catherine ^c   Alsarraf, Nicole W ^c   Gates, George A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

^c Univ of Washington Sch of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CAREGIVER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; MALE; OTITIS MEDIA;

EID: 0032975817     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.1.12     Document Type: Article

References (21)

1. Gates GA. Socioeconomic impact of otitis media. Pediatrics. 1983;71:648-649.
2. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg. 1996;114:525-530.
3. Kenna MA. Otitis media with effusion. In: Bailey BJ, ed. Head and Neck Surgery-Otolaryngology. Philadelphia, Pa: JB Lippincott: 1993:1592-1606.
4. Gates GA, Avery CA, Cooper JC, Prihoda TJ. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med. 1987;317:1444-1451.
5. Gebhart DE. Tympanostomy tubes in the otitis media prone child. Laryngoscope. 1981;91:849-866.
6. Stool SE, Berg AO, Carney CT. Otitis media with effusion in young children. In: Clinical Practice Guideline Technical Report Number 12. Rockville, Md: US Dept of Health and Human Services, Agency for Health Care Policy and Research: 1994: 192-208. AHCPR publication 94-0622.
7. Facione N. Quality of life issues in chronic otitis media with effusion: parameters for future study. Int J Pediatr Otorhinolaryngol. 1991;22:167-179.
8. Klein JO, Chase C, Teele DW. Otitis media and the development of speech, language, and cognitive abilities at seven years of age. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent Advances in Otitis Media. Burlington, Ontario: BC Decker Inc; 1988;396-397.
9. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY: Oxford University Press: 1993.
10. Sullivan SD, Weiss KB. Assessing cost-effectiveness in asthma care: building an economic model to study the impact of alternative intervention strategies, Allergy. 1993;48:146-152.
11. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995;87:417-426.
12. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-721.
13. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326:862-866.
14. Berman S, Roark R, Luckey D. Theoretical cost effectiveness of management options for children with persisting middle ear effusions Pediatrics. 1994;93: 353-363.
15. Kaplan B, Wandstrat TL, Cunningham JR. Overall cost in the treatment of otitis media. Pediatr Infect Dis J. 1997;16(suppl 2):S9-S11.
16. Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clin Ther. 1996;18:160-182.
17. Alsarraf R, Jung CJ, Perkins J, Crowley C, Gates GA. Otitis media health status evaluation: a pilot study for the investigation of cost-effective outcomes of recurrent acute otitis media treatment. Ann Otol Rhinol Laryngol. 1998;107: 120-128.
18. Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB. National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med. 1996;154(suppl 3, pt 2):S84-S95.
19. Fairbanks DF, ed. Antimicrobial Therapy in Otolaryngology-Head and Neck Surgery. 8th ed. Alexandria, Va: American Academy of Otolaryngology-Head and Neck Surgery Foundation; 1996.
20. Edelstein EG, ed. Blue Book Essential Directory of Pharmaceuticals. New York, NY: Hearst: 1996.
21. Max W, Rice D, MacKenzie EJ. The lifetime cost of injury. Inquiry. 1990;27: 332-343.